Literature DB >> 21317912

Does ethnicity matter in male hormonal contraceptive efficacy?

Niloufar Ilani1, Peter Y Liu, Ronald S Swerdloff, Christina Wang.   

Abstract

The development of male hormonal contraception has progressed significantly during the last three decades. The ultimate goal is to produce an effective, safe and reversible male method of contraception that are within reach of and can be used by all men globally. This review aims to outline the recent developments in male hormonal contraception with special emphasis on how ethnicity influences acceptability, extent of sperm suppression, and rate of recovery of spermatogenesis. Baseline differences in testicular histomorphology and testosterone metabolism between East Asian and Caucasian men have been reported, but whether this contributes significantly to varying degrees of sperm suppression in response to exogenous testosterone therapy is less known. Testosterone alone male hormonal contraceptive regimens are effective and applicable for East Asian men, and less so for Caucasians. Combinations of progestins with androgens are sufficient to optimize effectiveness of suppression and applicability to all ethnicities. New compounds such as steroidal or non-steroidal selective androgen receptor modulators with dual androgenic and progestational activities are potential compounds for further development as male hormonal contraceptive methods. At the present time, combined androgen and progestin contraceptive regimens appear to be effective, safe, reversible and convenient to use for all men with ethnic, cultural and environmental differences. Further refinements on the hormonal agent, methods of delivery, and dose optimization of the androgen relative to the progestin are necessary. This goal mandates further investment and large clinical trials in multiethnic populations to better define safety and efficacy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21317912      PMCID: PMC3739610          DOI: 10.1038/aja.2010.133

Source DB:  PubMed          Journal:  Asian J Androl        ISSN: 1008-682X            Impact factor:   3.285


  55 in total

Review 1.  Male contraception.

Authors:  R A Anderson; D T Baird
Journal:  Endocr Rev       Date:  2002-12       Impact factor: 19.871

Review 2.  Progress towards hormonal male contraception.

Authors:  Axel Kamischke; Eberhard Nieschlag
Journal:  Trends Pharmacol Sci       Date:  2004-01       Impact factor: 14.819

Review 3.  Male hormonal contraception.

Authors:  Christina Wang; Ronald S Swerdloff
Journal:  Am J Obstet Gynecol       Date:  2004-04       Impact factor: 8.661

4.  Testicular size: the effects of aging, malnutrition, and illness.

Authors:  D J Handelsman; S Staraj
Journal:  J Androl       Date:  1985 May-Jun

5.  A multicenter contraceptive efficacy study of injectable testosterone undecanoate in healthy Chinese men.

Authors:  Yi-Qun Gu; Xing-Hai Wang; Dwo Xu; Lin Peng; Li-Fa Cheng; Ming-Kong Huang; Zhen-Jia Huang; Gui-Yuan Zhang
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

6.  Contraceptive efficacy of a depot progestin and androgen combination in men.

Authors:  Leo Turner; Ann J Conway; Mark Jimenez; Peter Y Liu; Elise Forbes; Robert I McLachlan; David J Handelsman
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

7.  Testosterone metabolic clearance and production rates determined by stable isotope dilution/tandem mass spectrometry in normal men: influence of ethnicity and age.

Authors:  Christina Wang; Don H Catlin; Borislav Starcevic; Andrew Leung; Emma DiStefano; Geraldine Lucas; Laura Hull; Ronald S Swerdloff
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

8.  Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects.

Authors:  D P Lookingbill; L M Demers; C Wang; A Leung; R S Rittmaster; R J Santen
Journal:  J Clin Endocrinol Metab       Date:  1991-06       Impact factor: 5.958

9.  Contraceptive efficacy of testosterone-induced azoospermia in normal men. World Health Organization Task Force on methods for the regulation of male fertility.

Authors: 
Journal:  Lancet       Date:  1990-10-20       Impact factor: 79.321

Review 10.  Selective androgen receptor modulators in preclinical and clinical development.

Authors:  Ramesh Narayanan; Michael L Mohler; Casey E Bohl; Duane D Miller; James T Dalton
Journal:  Nucl Recept Signal       Date:  2008-11-26
View more
  13 in total

1.  Male contraception: Where do we go from here?

Authors:  C Yan Cheng; Dolores D Mruk
Journal:  Spermatogenesis       Date:  2011-10-01

Review 2.  Pipeline for contraceptive development.

Authors:  Diana L Blithe
Journal:  Fertil Steril       Date:  2016-08-11       Impact factor: 7.329

3.  The apical ectoplasmic specialization-blood-testis barrier functional axis is a novel target for male contraception.

Authors:  Ka-Wai Mok; Pearl P Y Lie; Dolores D Mruk; Jayakanthan Mannu; Premendu P Mathur; Bruno Silvestrini; C Yan Cheng
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 4.  Male hormonal contraception.

Authors:  Mara Y Roth
Journal:  Virtual Mentor       Date:  2012-02-01

Review 5.  Male hormonal contraception: looking back and moving forward.

Authors:  M Y Roth; S T Page; W J Bremner
Journal:  Andrology       Date:  2015-10-09       Impact factor: 3.842

6.  A new combination of testosterone and nestorone transdermal gels for male hormonal contraception.

Authors:  Niloufar Ilani; Mara Y Roth; John K Amory; Ronald S Swerdloff; Clint Dart; Stephanie T Page; William J Bremner; Regine Sitruk-Ware; Narender Kumar; Diana L Blithe; Christina Wang
Journal:  J Clin Endocrinol Metab       Date:  2012-07-12       Impact factor: 5.958

Review 7.  Emerging approaches to male contraception.

Authors:  Arthi Thirumalai; John K Amory
Journal:  Fertil Steril       Date:  2021-04-27       Impact factor: 7.490

8.  Male contraception.

Authors:  Vivek Mathew; Ganapathi Bantwal
Journal:  Indian J Endocrinol Metab       Date:  2012-11

9.  Overlapping dose responses of spermatogenic and extragonadal testosterone actions jeopardize the principle of hormonal male contraception.

Authors:  Olayiwola O Oduwole; Natalia Vydra; Nicholas E M Wood; Luna Samanta; Laura Owen; Brian Keevil; Mandy Donaldson; Kikkeri Naresh; Ilpo T Huhtaniemi
Journal:  FASEB J       Date:  2014-03-05       Impact factor: 5.191

10.  Should cross-sex hormone treatment of transsexual subjects vary with ethnic group?

Authors:  Louis J Gooren
Journal:  Asian J Androl       Date:  2014 Nov-Dec       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.